Newsroom
News & Press
Company announcements, awards, and trade coverage where PBS Biotech is featured.
Latest
Oct 13, 2026Press ReleasePBS Biotech Collaborates with Analytics By Light to Advance In-Situ Morphology Monitoring for BiomanufacturingAnalytics By Light announced the µImager™ platform, an in-situ morphology monitoring technology designed to provide continuous visibility of cell and aggregate morphology during bioprocessing. The company highlighted ongoing demonstration work with PBS Biotech to evaluate how real-time morphology measurements can complement traditional process analytics and support earlier process insight in biomanufacturing workflows.Read moreSep 29, 2026Press ReleasePBS Biotech Industrializes Cell Therapy Development with Rockwell AutomationThe MiniPRO, a 24-vessel parallel bioreactor platform utilizing Rockwell Automation, is now shipping to process-development groups running closed, single-use screening at bench-top scale.Read moreJul 29, 2026Press ReleasePBS Biotech Joins Organoid COMMONSPBS Biotech joins a collaboration with biopharma pioneers to establish the biomanufacturing standards and scalable frameworks required to transition organoid technologies from early-stage drug discovery to commercial-scale application.Read moreJul 21, 2026AwardCell Therapy Products Development AwardPBS Biotech has been named Cell Therapy Products Development of the Year 2026 and recognized among the Top Companies in Cell and Gene Therapy by Life Sciences Review, highlighting the company's leadership in advancing scalable cell therapy manufacturing through its patented Vertical-Wheel® Technology.Read moreDec 2, 2025Press ReleasePBS Biotech Unveils a Breakthrough Product for Cell Therapy Process Development at ISSCR, BostonIntroducing the MiniPRO™, a multi-parallel Vertical-Wheel® bioreactor platform that enables up to 24 independently controlled cultures, each with dedicated process analytics and automation, helping cell therapy developers accelerate process optimization and confidently scale manufacturing from R&D to clinical production.Read moreNov 3, 2025Press ReleasePBS Biotech Appoints Martin Simonetti as Chief Executive Officer to Support Next Phase GrowthWith more than 40 years of biotech leadership experience, Martin Simonetti has been appointed CEO of PBS Biotech, positioning the company to expand its impact and support the growing demand for advanced cell therapy bioprocessing solutions.Read moreIn The NewsPBS Biotech Building the Path to Large-Scale Cell TherapiesFeatured in Life Sciences Review, PBS Biotech's approach to scalable, low-shear bioprocessing demonstrates how advanced bioreactor technology can support the successful transition of cell therapies from the lab to commercial manufacturing.Read moreJan 6, 2025Press ReleasePBS Biotech Secures $17M Capital and Expands Leadership TeamPBS Biotech secures $17 million in follow-on financing from Avego and BroadOak while strengthening its executive team and expanding manufacturing capacity to accelerate product innovation, process development services, and support the commercialization of next-generation cell and regenerative therapies.Read moreApr 8, 2024Press ReleasePBS Biotech Certifies its Quality Management SystemsPBS Biotech achieves ISO 9001:2015 certification for its Quality Management System, demonstrating its commitment to maintaining rigorous quality standards and delivering reliable single-use bioreactor systems and process development services for the cell therapy industry.Read more
For Journalists
Media Kit
Logos, product photography, executive headshots, and a one-page company fact sheet.
Brand & media kit (ZIP)Contact Us
How Can We Help?
Tell us what you need and we’ll take it from there.